MBBS (Hons I) (University of Sydney), 1995
Fellow of the Royal Australian College of Physicians, 2002
PhD, (University of Sydney), 2008
Professor Jardine is the Director of the University of Sydney NHMRC Clinical Trials Centre, and a Professor of Medicine at the University of Sydney. She holds a Conjoint position with UNSW and an Honorary appointment at The George Institute. Prof Jardine a is a practising physician at Concord Repatriation Hospital. Her research has focused on investigating the progression and complications of non-communicable diseases, particularly kidney disease and diabetes, through randomised trials and epidemiological analyses. Prof Jardine has a particular interest in expanding the use of innovative and cost-effective methodologies to increase the generation of high-quality evidence. She is an experienced leader of trial collaborations focussing the on improving outcomes for people living with chronic kidney disease or diabetes, or experiencing COVID-19 infection. Prof Jardine is involved in national and international guidelines and policy development with roles including Executive Member of the international KIDGO nephrology guidelines committee, Board Member of the Kidney Health Initiative (collaboration of the American Society of Nephrology, FDA and other stakeholders), Board member of ACTA and member of the Research Advisory Committee to the national nephrology association (ANZSN). She is incoming Chair of the International Society of Nephrology Advancing Clinical Trials (ISN-ACTs) Group and has served as Deputy Chair of the Scientific Advisory Committee of the Australasian Kidney Trials Network (AKTN). Prof Jardine has led the curriculum of international conference streams and satellite programs for the World Congress of Nephrology. In 2020 she was honoured to receive the ANZSN TJ Neale Award for Outstanding Contribution to Nephrological Science.
MRFF Respiratory Medicine Clinical Trials Research on Covid-19 Grant (APP2002277); Repurposing existing medications to reduce severe acute respiratory distress in patients with COVID-19: the CLARITY trial. CIA; AUD$1,406,587
TJ Neale award for contributions to nephrological science, 2020.
KHA Clinical Science Award, Australian and New Zealand Society of Nephrology (ANZSN) Annual Scientific Meeting (ASM), Melbourne Australia, 2014
John Chalmers Award for best original paper by a post-doctoral fellow, 2010
Finalist: Kidney Health Australia Clinical Research Award. Australia and New Zealand Society of Nephrology Annual Conference 2010.
Finalist: Young Investigator’s Award, ANZSN ASM, 2005, Wellington, NZ
Young Investigator’s Award, TSANZ conference, 2004
GlaxoSmithKline Travel Award for Research in Transplantation, Awarded at TSANZ conference, 2001
Young Investigator’s Award, TSANZ conference 2001
University of Sydney Union Phillips Fox Leadership Prize – ‘for leadership excellence in service to the wider university community’, 1992
Welch Allyn prize – ‘for person who has contributed most to the year’ elected by secret ballot of Med 3 students, 1991
My research interests centre on the use of innovative and cost-effective methodologies to investigate the impact of pharmaceutical, device and health service interventions on outcomes for people with chronic disease. My research has focussed on investigating the progression and complications of kidney disease and diabetes through epidemiological analyses of large scale datasets and the development and implementation of randomised clinical trials.